Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Grygoriy Rekhtman"'
Autor:
Elena Litvinskaya, Janusz Kloczko, Tadeusz Robak, Ewa Lech-Marańda, Justyna Rybka, Grygoriy Rekhtman, Sebastian Grosicki, Wojciech Homenda, Javier Loscertales, Tommaso Stefanelli, Iryna Kriachok, Ghislaine Vincent, Kanakasetty Govind Babu, Jerzy Z. Blonski, Hiya Banerjee
Publikováno v:
Leukemialymphoma. 61(7)
Anti-CD20 monoclonal antibodies (mAbs) in combination with chemotherapies have changed the treatment landscape for chronic lymphocytic leukemia (CLL) [1]. Rituximab added to fludarabine with cyclop...
Autor:
Udvardy, Miklos, Vladimir, Strugov, Catharina, Lewerin, Sebastian, Grosicki, Grzegorz, Mazur, Michael, Steurer, Marco, Montillo, Irina, Kryachok, Jan M, Middeke, Grygoriy, Rekhtman, Tommaso, Stefanelli, Ghislaine, Vincent, Sameera, Govindaraju, Anders, Österborg
Publikováno v:
British journal of haematologyReferences. 189(4)
In 2014, an interim analysis of a phase 3 study was performed to evaluate the effectiveness of ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukaemia (BFR CLL) as compared to physician's choice. The five-year follow-up
Autor:
Mohamad Mohty, Evangelos Terpos, Maria-Victoria Mateos, Michele Cavo, Sandra Lejniece, Meral Beksac, Mohamed Amine Bekadja, Wojciech Legiec, Meletios Dimopoulos, Svetlana Stankovic, Maria Soledad Durán, Valerio De Stefano, Alessandro Corso, Yulia Kochkareva, Edward Laane, Christian Berthou, Hans Salwender, Zvenyslava Masliak, Valdas Pečeliūnas, Wolfgang Willenbacher, João Silva, Vernon Louw, Damir Nemet, Zita Borbényi, Uri Abadi, Robert Schou Pedersen, Peter Černelč, Anna Potamianou, Catherine Couturier, Caroline Feys, Florence Thoret-Bauchet, Mario Boccadoro, Mohamed Bekadja, Rose-Marie Hamladji, Hocine Ait Ali, Selma Hamdi, Hadj Touhami, Nourredine Sidi Mansour, Werner Linkesch, Robert Shou Pedersen, Niels Abildgaard, Marju Hein, Jean Richard Eveillard, Abderrazak el Yamani, Philippe Moreau, Laurence Sanhes, Gérard Lepeu, Kamel Laribi, Eric Jourdan, Olivier Fitoussi, Olivier Allangba, Joël Fleury, Martine Escoffre, Riad Benramdane, Guillaume Cartron, Gérard Dine, Eric Legouffe, Hanns-Detlev Harich, Thomas Illmer, Steffen Dörfel, Carla Verena Hannig, Michael Koenigsmann, Gabriele Prange-Krex, Ingo Tamm, Wolfgang Zeller, Michael Maasberg, Rudolf Schlag, Martine Klausmann, Jens Uhlig, Burkhard Alkemper, Stefan Schütz, Hans-Werner Tessen, Benno Mohr, Peter Schmidt, Bernhard Heinrich, Holger Hebart, Gernot Seipelt, Thomas Zoeller, Frank Heits, Clemens Müller-Naendrup, Richard Hansen, Roland Repp, Ludwig Fischer Von Weikersthal, Rudolf Schmits, Jörg Heßling, B. Krammer-Steiner, Viktor Janzen, Michael Schauer, Marcus W. Grüner, Jens Kisro, Claudio Denzlinger, Werner Freier, Christian Junghanss, Martin Görner, Katharina Laichinger, Helmut Ostermann, Heinz Dürk, Georg Hess, Gernot Reich, Panagiota Matsouka, Anastasia Pouli, Achilles Anagnostopoulos, Tamas Masszi, Janos Ivanyi, Arpad Szomor, Arnon Nagler, Hila Magen, Irit Avivi, Miriam Quitt, Antonio Palumbo, Tommaso Za, Daniele Vallisa, Roberto Foa, Alberto Bosi, Angelo Vacca, Francesco Lanza, Giulia Palazzo, Giuseppe Avvisati, Felicetto Ferrara, Ugo Consoli, Maria Cantonetti, Emanuele Angelucci, Catello Califano, Francesco Di Raimondo, Attilio Guarini, Maurizio Musso, Michele Pizzuti, Nicola Giuliani, Antonio Ardizzoia, Nicola Di Renzo, Gianluca Gaidano, Alessandro Gozzetti, Vincenzo Pitini, Gabriella Farina, Riccardo Centurioni, Paolo De Fabritiis, Francesco Iuliano, Giorgio La Nasa, Giacinto La Verde, Fabrizio Pane, Umberto Recine, Maria La Targia, Giuseppe Mineo, Clotilde Cangialosi, Daniele Fagnani, Augusto Federici, Atelda Romano, Giorgina Specchia, Sergio Storti, Velia Bongarzoni, Andrea Bacigalupo, Marco Gobbi, Giancarlo Latte, Donato Mannina, Silvana Capalbo, Mindaugas Jurgutis, Dariusz Woszczyk, Jadwiga Hołojda, Slawomir Gornik, Andrzej Pluta, Elzbieta Morawiec-Szymonik, Slawomira Kyrcz-Krzemien, Wojciech Homenda, Sebastian Grosicki, Kazimierz Sulek, Andrzej Lange, Janusz Kloczko, Jolanta Starzak-Gwozdz, Andrzej Hellmann, Mieczyslaw Komarnicki, Kazimierz Kuliczkowski, Carolina Viveiros, Cristina Gonçalves, Natalia Esefyeva, Julia Kochkareva, Kamil Kaplanov, Elena Volodicheva, Elena Laricheva, Valentina Dergacheva, Marina Chukavina, Natalia Volchenko, Irina Nazarova, Ludmila Anchukova, Elena Ovanesova, Taras Gritsenko, Galina Salogub, Ludmila Magomedova, Irina Kuznetsova, Svetlana Osyunikhina, Olga Serdyuk, Elena Karyagina, Valentina Ivanova, Slovenia Peter Černelč, Corlia Coetzee, Karen Gunther, Dhayanithi Moodley, Soledad Duran, Asunción Echeveste Gutiérrez, Jaime Perez De Oteyza, Francisco Javier Capote, Maria Casanova, Jesus Martin Sanchez, Eduardo Rios-Herranz, Jeronima Ibañez-Garcia, Maria Jose Herranz, Belen Hernandez, Sara Sanchez Sanchez, Fernando Escalante, Fernando Carnicero, Joan Bargay Lleonart, Mercedes Gironella, Rafael Martínez, Ana Lopez De La Guia, Luis Palomera, Rebeca Iglesias, Fernando Solano Ramos, Javier De La Serna, Pedro Garcia Sanchez, Juan Besalduch Vidal, Miguel Diaz Morfa, Turkey – Meral Beksac, Filiz Vural, Yildiz Aydin, Ali Unal, Hakan Goker, Oktay Bilgir, Birol Guvenc, Mehmet Turgut, Gulsum Gulistan Ozet, Ridvan Ali, Maryna Kyselyova, Nataliia Glushko, Renata Vybyrana, Igor Skrypnyk, Natalya Tretyak, Tetiana Kharchevska, Iryna Dyagil, Tetiana Popovs'ka, Vadim Shimanskiy, Tamila Lysa, Hanna Oliynyk, Kateryna Vilchevskaya, Iryna Kryachok, Yuriy Popovych, Natalia Romanyuk, Natalia Yushchenko, Polina Kaplan, Grygoriy Rekhtman, Halyna Pylypenko, Viktor Kozlov, Johannes Drach, Jean-Luc Harousseau, Hermann Einsele, Hartmut Goldschmidt, Thierry Facon, Mauricette Michalet, Valery G. Savchenko, Javier De la Rubia, Gordon Cook, Ulf-Henrik Mellqvist, Heinz Ludwig
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Clinical Lymphoma, Myeloma & Leukemia
Clinical Lymphoma, Myeloma & Leukemia, Elsevier, 2018, ⟨10.1016/j.clml.2018.06.018⟩
EMMOS Investigators & Abildgaard, N 2018, ' Multiple Myeloma Treatment in Real-world Clinical Practice : Results of a Prospective, Multinational, Noninterventional Study ', Clinical Lymphoma, Myeloma & Leukemia, vol. 18, no. 10, pp. e401-e419 . https://doi.org/10.1016/j.clml.2018.06.018
instname
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Clinical Lymphoma, Myeloma & Leukemia
Clinical Lymphoma, Myeloma & Leukemia, Elsevier, 2018, ⟨10.1016/j.clml.2018.06.018⟩
EMMOS Investigators & Abildgaard, N 2018, ' Multiple Myeloma Treatment in Real-world Clinical Practice : Results of a Prospective, Multinational, Noninterventional Study ', Clinical Lymphoma, Myeloma & Leukemia, vol. 18, no. 10, pp. e401-e419 . https://doi.org/10.1016/j.clml.2018.06.018
© 2018 The Authors.
[Background]: The present prospective, multinational, noninterventional study aimed to document and describe real-world treatment regimens and disease progression in multiple myeloma (MM) patients. [Patients and Methods]: Ad
[Background]: The present prospective, multinational, noninterventional study aimed to document and describe real-world treatment regimens and disease progression in multiple myeloma (MM) patients. [Patients and Methods]: Ad
Autor:
K Govind Babu, Sebastian Grosicki, Yaroslav Kulyaba, Steen Lisby, Javier Loscertales, Tadeusz Robak, Grygoriy Rekhtman, Iryna Kryachok, Jerzy Z. Blonski, Krzysztof Warzocha, Kazimierz Kuliczkowski, Astrid McKeown, Wojciech Homenda, V Bal, Kudrat Abdulkadyrov, Chai-Ni Chang, Janusz Kloczko, Ira Gupta
Publikováno v:
Leukemialymphoma. 58(7)
Chronic lymphocytic leukemia (CLL) is an incurable disease. Quality of life during treatment and periods of subsequent remission is therefore vital. Health-related quality of life (HRQoL) was compared in relapsed CLL during and after treatment with o
Autor:
Ira Gupta, K Govind Babu, Javier Loscertales, Sebastian Grosicki, Grygoriy Rekhtman, Kudrat Abdulkadyrov, Tadeusz Robak, Jerzy Z. Blonski, Chai-Ni Chang, Iryna Kryachok, Michele Gorczyca, Kazimierz Kuliczkowski, Astrid McKeown, Yaroslav Kulyaba, Steen Lisby, Krzysztof Warzocha, Janusz Kloczko, Wojciech Homenda, Jodi L Carey
Publikováno v:
Leukemialymphoma. 58(5)
In this multicenter, open-label, phase III study, patients with relapsed chronic lymphocytic leukemia (CLL) were randomized (1:1) to receive ofatumumab plus fludarabine and cyclophosphamide (OFA + FC) or FC alone; the primary endpoint being progressi
Autor:
MinKyu Heo, Atanas Radinoff, Figen Atalay, Hatice Oncel, Nikolay Tzvetkov, Adem Sahin, Yang Sang-In, Senem Ertan-Ahmed, Yoon-Jeong Choi, Young Chul Sung, Yuri Choi, Michael G. Kiehl, Burhan Turgut, Grygoriy Rekhtman, Rodica Mihăescu, Düzgün Özatlı, Seok-Gu Cho, Vasko Graklanov
Publikováno v:
Journal of Clinical Oncology. 37:e19065-e19065
e19065 Background: G-CSF is used in patients at significant risk for developing severe neutropenia (neutrophil count < 0.5 × 109/L or grade 4 neutropenia) following myelosuppresive chemotherapy. GX-G3, human G-CSF fused to hyFc is a proposed alterna
Autor:
Justyna Rybka, Wojciech Homenda, Elena Litvinskaya, Jerzy Z. Blonski, Ewa Lech-Marańda, Tommaso Stefanelli, Sebastian Grosicki, Ghislaine Vincent, Tadeusz Robak, Janusz Kloczko, K Govind Babu, Hiya Banerjee, Grygoriy Rekhtman, Javier Loscertales, Irina Kryachok
Publikováno v:
Blood. 132:3151-3151
Introduction: COMPLEMENT 2 is a phase III, randomized, open-label study, which compared the efficacy of ofatumumab (OFA) in combination with fludarabine and cyclophosphamide (FC) vs FC therapy alone in patients (pts) with relapsed chronic lymphocytic
Autor:
Jan Moritz Middeke, Andrey Zaritskey, Anders Österborg, Michele Gorczyca, Anna Schuh, Ira Gupta, Grzegorz Mazur, Yaroslav Kulyaba, Steen Lisby, Miklós Udvardy, Michael Steurer, Per Andersson, Chai Ni Chang, Sebastian Grosicki, Marco Montillo, Polina Kaplan, Iryna Kryachok, Siobhan Daly, Grygoriy Rekhtman
Publikováno v:
Leukemialymphoma. 57(9)
We report results of a randomized, phase III study of ofatumumab versus physicians' choice treatment in patients with bulky fludarabine-refractory chronic lymphocytic leukemia and explore extended versus standard-length ofatumumab treatment. Patients
Autor:
Jan Moritz Middeke, Ira Gupta, Polina Kaplan, Grygoriy Rekhtman, Andrey Zaritskey, Grzegorz Mazur, Siobhan Daly, Miklós Udvardy, Marco Montillo, Yaroslav Kulyaba, Chang Chai-Ni, Per-Ola Andersson, Steen Lisby, Anders Österborg, Michael Steurer, Anna Schuh, Michele Gorczyca, Iryna Kryachok, Sebastian Grosicki
Publikováno v:
Blood. 124:4684-4684
OFA was approved for the treatment of fludarabine and alemtuzumab refractory CLL on the basis of a single-arm study which also included pts with BFR CLL. This open label, randomized, Phase III study of OFA or PC treatment in pts with CLL refractory t